rs760797899
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PP3_ModeratePP5_Moderate
The NM_000460.4(THPO):c.112C>T(p.Arg38Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000684 in 1,461,446 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000068 ( 0 hom. )
Consequence
THPO
NM_000460.4 missense
NM_000460.4 missense
Scores
6
9
4
Clinical Significance
Conservation
PhyloP100: 2.86
Publications
9 publications found
Genes affected
THPO (HGNC:11795): (thrombopoietin) Megakaryocytopoiesis is the cellular development process that leads to platelet production. The main functional protein encoded by this gene is a humoral growth factor that is necessary for megakaryocyte proliferation and maturation, as well as for thrombopoiesis. This protein is the ligand for MLP/C_MPL, the product of myeloproliferative leukemia virus oncogene. Mutations in this gene are the cause of thrombocythemia 1. Alternative promoter usage and differential splicing result in multiple transcript variants differing in the 5' UTR and/or coding region. Multiple AUG codons upstream of the main open reading frame (ORF) have been identified, and these upstream AUGs inhibit translation of the main ORF at different extent. [provided by RefSeq, Feb 2014]
THPO Gene-Disease associations (from GenCC):
- thrombocythemia 1Inheritance: AD Classification: STRONG, MODERATE Submitted by: ClinGen, Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- congenital amegakaryocytic thrombocytopeniaInheritance: AR Classification: MODERATE Submitted by: ClinGen
- familial thrombocytosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary isolated aplastic anemiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary thrombocytosis with transverse limb defectInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- congenital amegakaryocytic thrombocytopeniaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Uncertain_significance. The variant received 4 ACMG points.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.878
PP5
Variant 3-184375917-G-A is Pathogenic according to our data. Variant chr3-184375917-G-A is described in ClinVar as Pathogenic. ClinVar VariationId is 520806.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| THPO | NM_000460.4 | c.112C>T | p.Arg38Cys | missense_variant | Exon 3 of 6 | ENST00000647395.1 | NP_000451.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD2 exomes AF: 0.00000796 AC: 2AN: 251156 AF XY: 0.00000737 show subpopulations
GnomAD2 exomes
AF:
AC:
2
AN:
251156
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000684 AC: 10AN: 1461446Hom.: 0 Cov.: 32 AF XY: 0.00000963 AC XY: 7AN XY: 727014 show subpopulations
GnomAD4 exome
AF:
AC:
10
AN:
1461446
Hom.:
Cov.:
32
AF XY:
AC XY:
7
AN XY:
727014
show subpopulations
African (AFR)
AF:
AC:
0
AN:
33464
American (AMR)
AF:
AC:
0
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
26132
East Asian (EAS)
AF:
AC:
0
AN:
39700
South Asian (SAS)
AF:
AC:
1
AN:
86230
European-Finnish (FIN)
AF:
AC:
0
AN:
53404
Middle Eastern (MID)
AF:
AC:
0
AN:
5576
European-Non Finnish (NFE)
AF:
AC:
7
AN:
1111880
Other (OTH)
AF:
AC:
2
AN:
60344
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
1
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Inborn genetic diseases Pathogenic:1
Jan 20, 2019
Ambry Genetics
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Amegakaryocytic thrombocytopenia, congenital, 2 Pathogenic:1
Aug 28, 2023
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Benign
DANN
Pathogenic
DEOGEN2
Uncertain
T;T;.;.;.;.;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Benign
D
LIST_S2
Uncertain
.;D;.;D;D;D;D
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D;D;D;D;D;D;D
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;M;.;M;.;.;.
PhyloP100
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;.;.;D;D;.;.
REVEL
Pathogenic
Sift
Uncertain
D;.;.;D;D;.;.
Sift4G
Pathogenic
D;.;.;D;D;.;.
Polyphen
D;D;.;D;D;.;D
Vest4
MutPred
Loss of methylation at R38 (P = 0.0409);Loss of methylation at R38 (P = 0.0409);.;Loss of methylation at R38 (P = 0.0409);Loss of methylation at R38 (P = 0.0409);.;Loss of methylation at R38 (P = 0.0409);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.